Identification of novel Cdc7 kinase inhibitors as anti-cancer agents that target the interaction with Dbf4 by the fragment complementation and drug repositioning …
AN Cheng, YK Lo, YS Lin, TK Tang, CH Hsu… - …, 2018 - thelancet.com
Abstract Background Cdc7-Dbf4 is a conserved serine/threonine kinase that plays an
important role in initiation of DNA replication and DNA damage tolerance in eukaryotic cells …
important role in initiation of DNA replication and DNA damage tolerance in eukaryotic cells …
Drogas anticâncer em efluente hospitalar: método, ocorrência, avaliação preliminar de risco, degradação por fotólise e ozonização
DM Souza - 2018 - repositorio.ufsm.br
In the last decade, the demand for anti-cancer drugs has grown considerably. These
products are one of the drug classes with great potential to cause harm to the environment …
products are one of the drug classes with great potential to cause harm to the environment …
[PDF][PDF] Antidepresszívumok hatásai komorbid onkológiai és depressziós betegeknél
K Gábor, P LászLó - Neuropsychopharmacol Hung, 2018 - epa.niif.hu
A klinikus számára problémát jelenthet, hogy komorbiditás esetén az egyik kórfolyamat
terápiájában alkalmazott gyógyszer hogyan hat a másik betegségre. A daganatos …
terápiájában alkalmazott gyógyszer hogyan hat a másik betegségre. A daganatos …